Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.
Jones
E Anthony
EA
Department of Gastrointestinal and Liver Diseases, Academic Medical Center, Amsterdam, The Netherlands. E.A.Jones@amc.uva.nl
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid